A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Clinical trial NCT07769502 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07769502
- Sponsor
- AbbVie
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-22
- Primary completion
- 2028-11-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.